Drug intelligence / Profile preview

G007-LK

Development stage
Preclinical
Lead developer
University of Oslo
Modality
Small Molecules
Administration
Oral
01

Overview

G007-LK is a potent and selective small-molecule inhibitor of tankyrase 1 (TNKS1) and tankyrase 2 (TNKS2). It functions by binding to the adenosine pocket of the tankyrase PARP domain, which prevents the poly-ADP-ribosylation of AXIN proteins. This stabilization of AXIN leads to the degradation of β-catenin, thereby inhibiting the WNT/β-catenin signaling pathway. G007-LK also modulates YAP signaling. Preclinical research indicates that G007-LK can overcome resistance to immune checkpoint inhibitors, such as anti-PD-1 antibodies, in melanoma by promoting T-cell infiltration and enhancing the anti-tumor immune microenvironment.

02

Targets

TNKS (Poly(ADP-ribose) Polymerase 5a)TNKS2 (Tankyrase 2)

Beyond the preview

Go deeper on G007-LK.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G007-LK.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call